• Prescription Drug User Fee Act Reauthorization Op-Ed, Jeff Allen, PhD (October 2011)
• Congressional Testimony of Ellen Sigal, PhD, before Energy and Commerce (July 2011)
• Friends Study on FDA vs EMA Cancer Drug Approvals in Health Affairs (June 2011)
• President's Cancer Panel White Paper, Ellen Sigal, PhD (December 2010)
• The New Role of Academia in Drug Discovery & Development (December 2010)
• DIA Global Forum Artcile on Drug Information, Jeff Allen, PhD (October 2010)
• Testimony at National Dialogue for Healthcare Innovation, Ryan Hohman, JD (October 2010)
• Potential PDUFA-Related Priorities Letter to FDA (September 2010)
• Regulatory Science Congressional Support Letter (July 2010)
• Presentation by Ellen Sigal, PhD, on CER at AACR Annual Meeting (April 2010)
• Congressional Testimony of Jeff Allen, PhD, before Energy and Commerce (March 2010)
• Health Reform Support Letter To Congress (January 2010)
• Conference on Clinical Cancer Research White Paper (September 2009)
• Comparative Effectiveness Research White Paper (May 2009)
• Friends Testimony to the Federal Coordinating Council for CER (April 2009)
• Comparative Effectiveness Research Support Letter (December 2009)
•  Conference on Clinical Cancer Research White Paper (January 2009) 

Annual Reports

        2010                        2009                         2008                        2007